Table 2.
Days | Untreated | Restasis®-treated | EPCS-treated1 | S100-treated2 |
---|---|---|---|---|
0 | 13.08±1.56 | 15.08±4.16 | 14.50±0.70 | 14.33±0.68 |
P1 | 0.31 | 0.082 | 0.116 | |
P2 | 0.748 | 0.68 | ||
P3 | 0.686 | |||
P4 | 0.498 | |||
3 | 9.75±2.31 | 8.46±3.77 | 9.50±2.36 | 8.66±2.40 |
P1 | 0.064 | 0.468 | 0.348 | |
P2 | 0.163 | 0.45 | ||
P3 | 0.714 | |||
P4 | 0.823 | |||
5 | 9.0±2.16 | 11.25±1.21 | 13.16±2.38 | 13.83±2.25 |
P1 | 0.025* | 0.015* | 0.006* | |
P2 | 0.119 | 0.039* | ||
P3 | 0.628 | |||
P4 | 0.002* | |||
8 | 8.75±0.97 | 12.00±3.40 | 14.08±3.82 | 14.50±3.61 |
P1 | 0.071 | 0.017* | 0.009* | |
P2 | 0.342 | 0.246 | ||
P3 | 0.85 | |||
P4 | 0.020* | |||
10 | 8.10±2.13 | 11.75±1.54 | 14.58±1.11 | 14.91±2.20 |
P1 | 0.007* | 0.000* | 0.000* | |
P2 | 0.005* | 0.018* | ||
P3 | 0.749 | |||
P4 | 0.000* |
Notes: Each group consists of three rabbits with a total number of six eyes. Data are expressed as mean ± standard deviation.
Significant difference when P<0.05.
SCF-EPCS liposomes.
SCF-S100 liposomes. P1: Restasis®-treated, EPCS-treated, and S100-treated groups are compared with the untreated group. P2: EPCS-treated and S100-treated groups are compared with the Restasis®-treated group. P3: S100-treated group is compared with the EPCS-treated group. P4: one-way ANOVA between the four groups. Restasis®, Allergan Inc., Irvine, CA, USA.
Abbreviations: ANOVA, analysis of variance; SCF-S100, supercritical fluid-mediated liposomes prepared using Lipoid S100; SCF, supercritical fluid; S100, phosphatidylcholine from soybean lecithin; EPCS, phosphatidylcholine from egg lecithin; SCF-EPCS, supercritical fluid-mediated liposomes prepared using Lipoid EPCS.